113 - POLYCLONAL Vβ21.3 EXPANSION IN POST-VACCINATION MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
Location: St-Laurent
Author: Stejara A. Netea, n/a – Pediatric Hematology-Immunology-infectious diseases, Emma Children's Hospital, Amsterdam, Netherlands
2:40 PM – 3:00 PM East Coast USA Time
116 - FOUR GRAND-PARENTS ETHNIC ORIGIN OF KD AND MIS-C PATIENTS. THE MONTRÉAL OBSERVATION DURING THE SARS-COV-2 PANDEMIC
Location: St-Laurent
Author: Joe Abou Abdallah, n/a – division of Pediatric Cardiology, CHU Sainte-Justine, University of Montreal, Canada
2:40 PM – 3:00 PM East Coast USA Time
118 - INCREASED OXIDATIVE STRESS MARKERS (NITRIC OXIDE, REACTIVE OXYGEN SPECIES) INDUCE ENDOTHELIAL DYSFUNCTION IN KAWASAKI DISEASE PATIENTS ON FOLLOW-UP- THE FIRST STUDY FROM THE INDIAN SUBCONTINENT
Location: St-Laurent
Author: RAJNI KUMRAH, PhD – Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2:40 PM – 3:00 PM East Coast USA Time
127 - EVALUATION OF MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH KAWASAKI DISEASE ON FOLLOW-UP USING FLOWCYTOMETRY, TRANSCRIPTOMICS AND PROTEOMICS- THE FIRST SUCH STUDY FROM THE INDIAN SUBCONTINEN
Location: Poster hall
Author: RAJNI KUMRAH, PhD – Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2:40 PM – 3:00 PM East Coast USA Time
128 - LONG-TERM PROGNOSIS OF KAWASAKI DISEASE: PREVIOUS FINDINGS AND INTERIM ANALYSIS OF THE PROSPECTIVE COHORT STUDY
Location: St-Laurent
Author: Koki Kosami, M.D. – Division of Public Health, Center for Community Medicine, Jichi Medical University
2:40 PM – 3:00 PM East Coast USA Time
143 - IMMUNE CHECKPOINT MOLECULE PROGRAMMED DEATH-LIGAND 1 EXPRESSION IN KAWASAKI DISEASE: A PILOT STUDY FROM CHANDIGARH, NORTH INDIA
Location: St-Laurent
Author: PALLAVI L. NADIG, MD – ALLERGY IMMUNOLOGY UNIT, ADVANCED PEDIATRICS CENTER, POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH
2:40 PM – 3:00 PM East Coast USA Time
148 - CAN VARIABILITY IN THE WIND EXPLAIN EPIDEMIOLOGICAL FEATURES OF KAWASAKI DISEASE IN JAPAN?
161 - UNRAVELLING THE INFLAMMASOME CASCADE IN KD PATHOGENESIS: AN ARENA THAT HAS REMAINED UNEXPLORED SO FAR
Author: DEEPTI SURI, MD – Post graduate institute of medical education and research
Immunology
2:40 PM – 3:00 PM East Coast USA Time
173 - EPIDEMIOLOGICAL SHIFTS IN KAWASAKI DISEASE INCIDENCE DURING AND AFTER THE COVID-19 PANDEMIC: OBSERVATIONS FROM CHANDIGARH, NORTH INDIA, DURING THE PERIOD JANUARY 2020- DECEMBER 2023
200 - ANTIBODIES TARGETING HIV GP41 IDENTIFY PEPTIDES WITH SIMILARITY TO PROPOSED KAWASAKI DISEASE RELATED PEPTIDE, SUGGESTING NON-SPECIFIC MIMOTOPE TARGETING BY ACIDIC AMINO ACID ENRICHED REGIONS
Author: MARK D. HICAR, MD/PhD – Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
2:40 PM – 3:00 PM East Coast USA Time
202 - INVESTIGATION OF PATIENT ETHNIC ORIGINS UNVEILS NEW INSIGHTS INTO THE EPIDEMIOLOGY OF KAWASAKI DISEASE IN THE PROVINCE OF QUEBEC, CANADA
23 - EFFICACY OF ANGIOTENSIN II RECEPTOR BLOCKER/ANGIOTENSIN CONVERTING ENZYME FOR CORONARY ARTERY ANEURYSM REGRESSION IN JAPANESE PATIENT WITH KAWASAKI DISEASE
Location: Outremont
Author: Eisuke Suganuma, M.D., Ph.D. – Division of Infectious Diseases, and Immunology, Allergy, Saitama Children's Medical Center
Therapeutics
3:15 PM – 4:00 PM East Coast USA Time
24 - REDUCED CAPILLARY DENSITY IN THE MYOCARDIUM OF THE PATIENTS WITH KD HISTORY
37 - A MULTI-CENTER, NON-INFERIORITY STUDY TO EVALUATE THE EFFICACY OF ELIMINATION OF HIGH-DOSE ASPIRIN IN THE ACUTE STAGE OF KAWASAKI DISEASE FOR PREVENTING CORONARY ARTERY LESIONS (KIAA TRIAL)
43 - A PHASE I/IIA TRIAL OF ATROVASTATIN IN JAPANESE PATIENTS WITH ACUTE KAWASAKI DISEASE AND CORONARY ARTERY ANEURYSMS: A MULTICENTER, SINGLE-ARM, OPEN-LABEL TRIAL
Location: Outremont
Author: KENJI FURUNO, MD – Fukuoka Children's Hospital and Japanese Red Cross Fukuoka Hospital
Therapeutics
3:15 PM – 4:00 PM East Coast USA Time
55 - PATHOLOGICAL FEATURES OF CORONARY ARTERITIS SEQUALAE IN ADULTS WITH A HISTORY OF KAWASAKI DISEASE
Location: Outremont
Author: Yuki Yokouchi, MD, PhD – Department of pathology, Toho University Ohashi Medical Center
Etiology/Basic science
3:15 PM – 4:00 PM East Coast USA Time
59 - EVALUATING THE EFFICACY OF ESTABLISHED SCORES IN PREDICTING IVIG RESISTANCE IN INFANT KAWASAKI DISEASE
Location: Outremont
Author: Young Tae Lim, n/a – Department of Pediatrics, Kyungpook National University School of Medicine Hospital
Clinical Management
3:15 PM – 4:00 PM East Coast USA Time
66 - TIPS AND TRICKS FOR RADIATION OPTIMIZED COMPUTED TOMOGRAPHY ANGIOGRAPHY IN 298 CHILDREN WITH KD: OUR EXPERIENCE OVER 10 YEARS
Location: Outremont
Author: MANPHOOL SINGHAL, n/a – Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA
Imaging
3:15 PM – 4:00 PM East Coast USA Time
78 - EARLY USE OF ADJUNCTIVE THERAPY TO REDUCE CORONARY ARTERY DAMAGE FROM KAWASAKI DISEASE IN HIGH-RISK INFANTS LESS THAN 6 MONTHS OF AGE: A TWO-CENTER EXPERIENCE
96 - DIAGNOSTIC VALUE OF 99MTC-MIBI MYOCARDIAL PERFUSION IMAGING IN DETECTING MYOCARDIAL ISCHEMIA OF CHILDREN WITH KAWASAKI DISEASE AND CORONARY ARTERY LESIONS
Location: Montreal
Presenter: Yiting Gui, n/a – Children's hospital of Fudan university
Author: Yiting Gui, n/a – Children's hospital of Fudan university
Imaging
9:25 AM – 9:35 AM East Coast USA Time
6 - MULTI-MODAL PROFILING OF KAWASAKI DISEASE AND IMMUNE DYNAMICS FOLLOWING INTRAVENOUS IMMUNOGLOBULIN
Location: Montreal
Presenter: GIULIO OLIVIERI, n/a – 1. Clinical Immunology and Vaccinology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
Author: GIULIO OLIVIERI, n/a – 1. Clinical Immunology and Vaccinology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
Immunology
9:35 AM – 9:45 AM East Coast USA Time
162 - A HOST PROTEIN SIGNATURE TO DISTINGUISH KAWASAKI DISEASE FROM OTHER INFECTIOUS AND INFLAMMATORY DISEASES
82 - PREDICTING CORONARY ARTERY ABNORMALITIES DEVELOPMENT USING CORONARY Z SCORE AND CLINICAL PARAMETERS BEFORE THE TREATMENT FOR KAWASAKI DISEASE ¦ A MULTICENTER RETROSPECTIVE STUDY IN WAKAYAMA, JAPAN
177 - DEVELOPMENT AND DEPLOYMENT OF MISKD: A CLINICAL DECISION SUPPORT SYSTEM FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS ALONG THE KD TO MISC CLINICAL SPECTRUM USING AI-POWERED PREDICTIVE ALGORITHMS
60 - A DATA-DRIVEN MULTIOMIC APPROACH IDENTIFIES SHARED CLINICAL AND BIOLOGICAL SIGNATURES IN MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND KAWASAKI DISEASE
176 - DATA-DRIVEN CONCORDANCE OF CLINICAL PROFILE BETWEEN SUBSETS OF MIS-C AND PRE-PANDEMIC KD PATIENTS AS DETERMINED BY AN UNSUPERVISED MACHINE LEARNING ALGORITHM
106 - HEMODYNAMIC ANALYSIS AND RISK ASSESSMENT OF CORONARY ARTERY ANEURYSMS CAUSED BY KAWASAKI DISEASE USING PATIENT-SPECIFIC COMPUTATIONAL FLUID DYNAMICS
8 - HYDROGEN GAS INHALATION IMPROVE CORONARY ARTERY DILATION IN A MICE MODEL OF KAWASAKI DISEASE
Location: St-Laurent
Author: HO-CHANG KUO, n/a – Kawasaki disease center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Therapeutics
4:10 PM – 4:30 PM East Coast USA Time
12 - VERY LONG-TERM OUTCOME OF TRANSCATHETER POLYTETRAFLUOROETHYLENE-COVERED STENT IMPLANTATION IN A GIANT CORONARY ANEURYSM IN A CHILD WITH KAWASAKI DISEASE
Location: Poster hall
Author: Kenji Waki, n/a – Department of Pediatrics, Kurashiki Central Hospital
Therapeutics
4:10 PM – 4:30 PM East Coast USA Time
14 - RISK FACTORS FOR NON-RESPONSIVENESS TO SECOND COURSE OF INTRAVENOUS IMMUNOGLOBULIN MONOTHERAPY IN TAIWANESE CHILDREN WITH REFRACTORY KAWASAKI DISEASE: A MULTI-CENTER STUDY
Location: St-Laurent
Author: CHIA-YI CHIN, n/a – Department of Pediatrics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Diagnostics
4:10 PM – 4:30 PM East Coast USA Time
17 - CLINICAL CHARACTERISTICS OF KAWASAKI DISEASE IN ADOLESCENTS
Location: St-Laurent
Author: HEE JOUNG CHOI, n/a – Department of Pediatrics, Keimyung University School of Medicine
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
26 - CANADIAN PRACTICE POINT ON KAWASAKI DISEASE (KD) MANAGEMENT
40 - RISK FACTORS FOR CORONARY ARTERY ABNORMALITIES AND RESISTANCE TO IMMUNOGLOBULIN PLUS CICLOSPORIN A THERAPY IN SEVERE KAWASAKI DISEASE: SUBANALYSIS OF THE KAICA TRIAL
Location: St-Laurent
Author: Nobuyuki Kakimoto, MD – Department of Pediatrics, Wakaytama Medical University
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
44 - A PILOT STUDY ON CLINICAL SAFETY AND EFFICACY OF COMBINATION THERAPY WITH COLCHICINE AND INTRAVENOUS IMMUNOGLOBULIN FOR KAWASAKI DISEASE
Location: St-Laurent
Author: Kentaro Aso, n/a – St. Marianna University School of Medicine, Department of Pediatrics
Therapeutics
4:10 PM – 4:30 PM East Coast USA Time
45 - MID-TERM OUTCOMES IN KAWASAKI DISEASE PATIENTS WITH GIANT CORONARY ARTERY ANEURYSM: A SINGLE CENTER EXPERIENCE
47 - RELIABLE PREDICTION OF CORONARY ARTERY LESIONS DUE TO THE TREATMENT-RESISTANT KAWASAKI DISEASE PRIOR TO INITIAL TREATMENT WITH NEUTROPHILS AND TOTAL BILIRUBIN VALUES
50 - ACUTE CORONARY SYNDROME DURING LONG-TERM FOLLOW-UP OF KAWASAKI DISEASE
Location: St-Laurent
Author: KAYO OGINO, MD – Department of Pediatrics, Kurashiki Central Hospital, Kurashiki, Japan
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
52 - EFFECT OF ADDITIONAL INTRAVENOUS IMMUNOGLOBULIN FOR INFLIXIMAB-REFRACTORY KAWASAKI DISEASE
Location: St-Laurent
Author: SATOKI HATANO, n/a – National Center for Child Health and Development
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
61 - MID-TERM FOLLOW-UP OF CORONARY ARTERY ANGIOPLASTY IN CHILDREN WITH GIANT CORONARY ARTERY ANEURYSM AFTER KAWASAKI DISEASE: A SINGLE-CENTER CASE SERIES OF 5 CASES
Location: St-Laurent
Author: FANG LIU, n/a – Cardiac Center, Children’s Hospital of Fudan University
Therapeutics
4:10 PM – 4:30 PM East Coast USA Time
62 - SCREENING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: ACCURACY OF THE AMERICAN COLLEGE OF RHEUMATOLOGY MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN SCREENING ALGORITHM
Location: St-Laurent
Author: GRETA MASTRANGELO, MD – Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada
Diagnostics
4:10 PM – 4:30 PM East Coast USA Time
63 - NT-PROBNP VARIATION ACCORDING TO THE TIME TO DIAGNOSIS IN MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
81 - BOYS AFFECTED WITH KAWASAKI DISEASE DEVELOP MEDIUM AND LARGE CORONARY ARTERY ANEURYSMS MORE THAN TWICE AS MUCH AS GIRLS
Location: St-Laurent
Author: Laurence Watelle, MD – Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke
Author: KENZA BOUAYED, n/a – Hôpital Mère-Enfant A. HAROUCI, CHU IBN ROCHD, Faculté de Médecine et de Pharmacie, Université Hassan II, Casablanca, Morocco
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
94 - FOLLOW-UP OF 112 CHILDREN WITH KAWASAKI DISEASE COMPLICATED WITH GIANT CORONARY ARTERY ANEURYSM
Location: St-Laurent
Author: Zhong-Dong Du, n/a – Deapartment of Cardiology, Beijing Children's Hospital, Capital Medical University; Amcare Clinics and Hospital, Amcare Healthcare System
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
105 - SAFETY AND TOLERABILITY OF COVID-19 VACCINATION IN INFANTS WITH A HISTORY OF KAWASAKI DISEASE
109 - VARIATION IN THE PROVISION OF KD CARE IN NORTH AMERICAN CENTERS INCLUDING CHANGES SINCE THE COVID-19 PANDEMIC: THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) SURVEY
110 - VARIATION IN TREATMENT APPROACHES TO KD AMONG PEDIATRIC RHEUMATOLOGISTS: THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) TREATMENT OF REFRACTORY KD SURVEY
112 - EVALUATION OF CORONARY CIRCULATION BY 13N-AMMONIA MYOCARDIAL PERFUSION POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH RIGHT CORONARY ARTERY OCCLUSION DUE TO KAWASAKI DISEASE
133 - FROM KAWASAKI TO MULTI SYSTEM INFLAMMATORY DISEASE : LEVERAGING INSIGHTS IN PEDIATRIC VASCULITIS IN THE CREATION OF AN ALGORITHM TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES
135 - ASSOCIATION OF ETHNICITY WITH CLINICAL FEATURES AND CARDIAC OUTCOMES FOR KD VERSUS MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH COVID-19: A STUDY OF THE INTERNATIONAL KD REGISTRY
136 - FACTORS ASSOCIATED WITH IMPORTANT CORONARY ARTERY ANEURYSMS FOR KAWASAKI DISEASE VERSUS MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH COVID-19: A STUDY OF THE INTERNATIONAL KD REGISTRY
137 - ASSESSMENT OF MYOCARDIAL STRUCTURE AND FUNCTION IN MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN USING CARDIAC MRI AND SERUM GALECTIN-3: FOLLOW-UP STUDY AFTER A MEAN DURATION OF 23.58 MONTHS
144 - THROMBOTIC CALCIFIED ANEURYSM IN A CHILD WITH KAWASAKI DISEASE AT 4 YEARS OF FOLLOW-UP
Location: St-Laurent
Author: PALLAVI L. NADIG, MD – ALLERGY IMMUNOLOGY UNIT, ADVANCED PEDIATRICS CENTER, POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH
Diagnostics
4:10 PM – 4:30 PM East Coast USA Time
145 - RESPONSE OF MEDIUM AND GIANT CORONARY ARTERY ANEURYSMS TO TREATMENT INTENSIFICATION WITH INFLIXIMAB WITH RESPECT TO IT'S TIME OF ADMINISTRATION AFTER INTRAVENOUS IMMUNOGLOBULIN: RETROSPECTIVE ANALYSIS
155 - CT CORONARY ANGIOGRAPHY IS THE PREFERRED IMAGING MODALITY FOR LEFT CIRCUMFLEX CORONARY ARTERY IN CHILDREN WITH KAWASAKI DISEASE: 9 YEARS OF EXPERIENCE FROM A TERTIARY CENTRE IN NORTH INDIA
156 - PERIPHERAL GANGRENE IN KAWASAKI DISEASE: A CLINICAL CONUNDRUM
Location: St-Laurent
Author: munish arora, n/a – PEDIATRIC ALLERGY AND IMMUNOLOGY,ADVANCED PEDIATRICS CENTRE,POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
158 - CICLOSPORIN IS USEFUL IN SEVERE KAWASAKI DISEASE: EXPERIENCE FROM A TERTIARY CARE CENTRE IN NORTH-WEST INDIA
Location: St-Laurent
Author: GAYATHRI C V, MBBS, MD – Pediatric Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh
Therapeutics
4:10 PM – 4:30 PM East Coast USA Time
159 - CALCIFICATIONS IN CORONARY ARTERY ANEURYSMS: OUR EXPERIENCE WITH CT CORONARY ANGIOGRAPHY (CTCA) OVER THE LAST 10 YEARS
171 - CARDIAC MAGNETIC RESONANCE IMAGING FOR ASSESSMENT OF MYOCARDIAL STRUCTURE AND FUNCTION AT MINIMUM 10 YEARS OF FOLLOW-UP IN CHILDREN WITH KD
Location: St-Laurent
Author: MANPHOOL SINGHAL, n/a – Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA
Imaging
4:10 PM – 4:30 PM East Coast USA Time
172 - CONGENITAL CORONARY ARTERY ANOMALIES ARE LIABLE TO BE MISINTERPRETED AS CORONARY DILATATIONS IN CHILDREN WITH KAWASAKI DISEASE: LESSONS LEARNED FROM CT CORONARY ANGIOGRAPHY
Location: St-Laurent
Author: PALLAVI L. NADIG, MD – ALLERGY IMMUNOLOGY UNIT, ADVANCED PEDIATRICS CENTER, POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH
Imaging
4:10 PM – 4:30 PM East Coast USA Time
178 - JEJUNAL PERFORATION IN CONVALESCENT PHASE OF KD
Location: St-Laurent
Author: GAYATHRI C V, MBBS, MD – Pediatric Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
181 - KD WITH LEFT ABDUCENS PALSY: A RARE NEUROLOGICAL MANIFESTATION
Location: St-Laurent
Author: GAYATHRI C V, MBBS, MD – Pediatric Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
182 - TRANSITIONAL CARE FOR KD PATIENTS: A QUESTIONNAIRE TO RESPOND TO THE UNMET NEEDS
Location: St-Laurent
Author: MARIA CRISTINA MAGGIO, n/a – University Department PROMISE “G. D’Alessandro”, University of Palermo, Italy
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
183 - KD WITH LARYNGEAL WEAKNESS: A RARE PRESENTATION OF MYOSITIS
Location: St-Laurent
Author: GAYATHRI C V, MBBS, MD – Pediatric Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
184 - OUTCOMES AND MIDTERM MONITORING OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
187 - RISK FACTORS FOR PERSISTENT CORONARY ARTERY ABNORMALITIES IN ITALIAN CHILDREN WITH KAWASAKI DISEASE
Location: St-Laurent
Author: Marianna Fabi, n/a – Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
188 - RETROSPECTIVE ANALYSIS OF KAWASAKI DISEASE TREATMENT OUTCOMES IN POLAND'S POMERANIAN REGION (1997-2021)
Location: St-Laurent
Author: Agnieszka Herrador Rey, N/A, n/a – Department of Paediatric Cardiology and Congenital Heart Defects, Medical University of Gdansk, Poland
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
189 - PHARMACOECONOMICS APPLICATIONS IN OPTIMIZING KAWASAKI DISEASE MANAGEMENT ACROSS ARAB NATIONS: A MULTINATIONAL, MULTI-INSTITUTIONAL ENDEAVOR BY THE KAWASAKI DISEASE ARAB INITIATIVE (KAWARABI)
195 - CLINICAL, BIOLOGICAL AND CARDIAC CHARACTERISTICS OF PEDIATRIC INFLAMMATORY MULTISYTEMIC SYNDROME: A SINGLE CENTER EXPERIENCE
Location: St-Laurent
Author: KENZA BOUAYED, n/a – Hôpital Mère-Enfant A. HAROUCI, CHU IBN ROCHD, Faculté de Médecine et de Pharmacie, Université Hassan II, Casablanca, Morocco
Clinical Management
4:10 PM – 4:30 PM East Coast USA Time
199 - CREATION OF PREDICTION TOOL TO GUIDE FURTHER WORKUP OF FEBRILE CHILDREN IN THE EMERGENCY DEPARTMENT UNDER CONSIDERATION FOR MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C)
Location: St-Laurent
Author: LAUREN CHAVANNE, BS – Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Diagnostics
4:10 PM – 4:30 PM East Coast USA Time
201 - KAWASAKI DISEASE, MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND COVID-19 IN A TERTIARY PEDIATRIC HOSPITAL IN MONTREAL, CANADA
67 - ROLE OF COMPUTED TOMOGRAPHY ANGIOGRAPHY IN CHILDREN WITH KD AT PRESENTATION: A COMPARATIVE STUDY WITH ECHO
Location: Outremont
Author: MANPHOOL SINGHAL, n/a – Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA
Imaging
4:45 PM – 5:30 PM East Coast USA Time
76 - INCOMPLETE KAWASAKI DISEASE VERSUS NON-SEVERE MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DISTINGUISHING FEATURES FROM CONTEMPORANEOUS PATIENTS
77 - INHIBITION OF HIGH MOBILITY GROUP BOX-1 ATTENUATES IN THE LCWE-INDUCED MURINE MODEL OF KD VASCULITIS
Location: Outremont
Author: Kentaro Ueno, Doctor of Philosophy – Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences
Therapeutics
4:45 PM – 5:30 PM East Coast USA Time
80 - IDENTIFICATION OF EPIDEMIOLOGIC FEATURES OF KAWASAKI DISEASE USING BIG DATA ANALYSIS FROM THE NATIONAL DATABASE OF HEALTH INSURANCE CLAIMS AND SPECIFIC HEALTH CHECKUPS IN JAPAN
157 - ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS OF TGF-BETA PATHWAY IN NORTH INDIAN CHILDREN WITH KAWASAKI DISEASE: THE FIRST STUDY FROM THE INDIAN SUBCONTINENT
Location: Outremont
Author: munish arora, n/a – PEDIATRIC ALLERGY AND IMMUNOLOGY,ADVANCED PEDIATRICS CENTRE,POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA
Genetics
4:45 PM – 5:30 PM East Coast USA Time
160 - INNATE LYMPHOID CELLS: A NEW PARADIGM IN PATHOGENESIS OF KAWASAKI DISEASE
Location: Outremont
Author: KANIKA ARORA, M.Sc – Postgraduate institute of medical education and research
Immunology
4:45 PM – 5:30 PM East Coast USA Time
166 - GENETIC INSIGHTS INTO KAWASAKI DISEASE: FCGR2/3 LOCUS COPY NUMBER VARIATIONS AS KEY PLAYERS IN KAWASAKI DISEASE SUSCEPTIBILITY AND SEVERITY
